65
Carlo Aprile Carlo Aprile SC Medicina Nucleare SC Medicina Nucleare Fond.Policlinico S.Matteo,IRCCS Fond.Policlinico S.Matteo,IRCCS Pavia Pavia IMAGING IMAGING MEDICO- MEDICO- NUCLEARE NUCLEARE

Imaging con Scintigrafia

  • Upload
    cteph

  • View
    3

  • Download
    0

Embed Size (px)

DESCRIPTION

imaging con scintigrafia

Citation preview

Page 1: Imaging con Scintigrafia

Carlo AprileCarlo AprileSC Medicina NucleareSC Medicina Nucleare

Fond.Policlinico S.Matteo,IRCCSFond.Policlinico S.Matteo,IRCCSPaviaPavia

IMAGING IMAGING MEDICO-MEDICO-

NUCLEARENUCLEARE

Page 2: Imaging con Scintigrafia

Identification of CTEPH as the cause of PH is facilitated by several imaging techniques:

• Ventilation–Perfusion (V/Q) scintigraphy,

• multidetector CT Pulmonary Angiography (CTPA),

• High-Resolution CT (HRCT),• pulmonary Digital Subtraction

Angiography (DSA), • Magnetic Resonance Angiography

Page 3: Imaging con Scintigrafia

CTPA-large multicenter studyStein PD, et al. Multidetector computed tomography for acute pulmonary acute pulmonary embolismembolism. N Engl J Med. 2006;354:2317

sensitivity of 83% • specificity of 96%,• with even a lower sensitivity for segmental

(68%) and subsegmental (25%) branches

Pitton MB, et al. Chronic thromboembolic pulmonary Chronic thromboembolic pulmonary hypertensionhypertension: diagnostic impact of multislice-CT and selective pulmonary-DSA. Rofo. 2002;174:474.Multidetector CTPA

•sensitivity of 70.4% for segmental and• 63.6% for subsegmental branches

when compared with pulmonary DSA

Page 4: Imaging con Scintigrafia

Accuracy of Various Imaging Methods AgainstAccuracy of Various Imaging Methods AgainstPulmonary Angiography as the Reference Method to Pulmonary Angiography as the Reference Method to

Diagnose CTPHDiagnose CTPH

Lang et al. Imaging in Pulmonary Hypertension J A C C : C A R D I O V A S C U L A R I M A G I N G . 2 0 1 0; 3:1287

Page 5: Imaging con Scintigrafia

SCINTIGRAFIA POLMONARE DI PERFUSIONESCINTIGRAFIA POLMONARE DI PERFUSIONE

Page 6: Imaging con Scintigrafia

SCINTIGRAFIA POLMONARE VENTILATORIASCINTIGRAFIA POLMONARE VENTILATORIA

1. Sc VENTILATORIA CON AEROSOLAEROSOL : test diagnostico che visualizza la distribuzione broncopolmonare di un radioaerosol inalato

2. Sc. VENTILATORIA CON GAS RADIOATTIVIGAS RADIOATTIVI: test diagnostico che visualizza la distribuzione polmonare di un gas radioattivo inalato, durante le manovre respiratorie

3. Sc VENTILATORIA CON PSEUDOGASPSEUDOGAS (Technegas), range 60-160nm (media 97nm)

Page 7: Imaging con Scintigrafia

Limite dimensionale di valutazione del circolo periferico della metodica scintigrafica e TC.

Page 8: Imaging con Scintigrafia

F a.70 Ipertensione polmonare post-embolica, in attesa TEAP

Page 9: Imaging con Scintigrafia

SOSPETTA PE IN COPDSOSPETTA PE IN COPD

Page 10: Imaging con Scintigrafia

J Nucl Med 2007; 48:680–684

Page 11: Imaging con Scintigrafia

500 patients with PH referred to Hammersmith Hospital, London, between 2000 and 2005: 227 elegible pts

V/Q Images were interpreted according to the modified PIOPED criteria

1. A high-probability scan : suggestive of chronic thromboembolic pulmonary disease,

2. low-probability scan : suggestive of nonchronic thromboembolic pulmonary disease etiology.

1. For intermediate-probability scans: 2 separate datasets • In one as suggestive of chronic

thromboembolic pulmonary disease and, • in the other dataset, not suggestive of

chronic thromboembolic pulmonary disease

Page 12: Imaging con Scintigrafia

Multidetector CTPA- A report was considered as suggestive of chronic thromboembolic pulmonary disease if:

• visualization of the thrombus,• calcified thrombus, • recanalization, • sudden change in vessel caliber,• strictures,• poststenotic dilatation, • webs, or perfusion abnormality

Page 13: Imaging con Scintigrafia

Pulmonary DSA: indications (61/78 pts)

• (a) clinical suspicion of CTEPH,

• (b) at least one positive imaging modality for chronic thromboembolic pulmonary disease,and

• (c) whether the patient was being assessed for pulmonary thrombendarterectomy.

Page 14: Imaging con Scintigrafia

V/Q scan CTPAGroup Low

probabilityIntermediate

probabilityHigh

probabilityNegative Positive

A (n 78)

2FN

1 75 38FN

40

B (n 149)

134 78

FP148 1

Summary of V/Q Scans and CTPA Results

with CTEPH (group A, n 78 patients),

with non-CTEPH (group B, n 149 patients)

MP: Mosaic Perfusion

MP

43

10

Page 15: Imaging con Scintigrafia

V/Q Diagnosis

Intermediate probability

(n = 7)

IPAH (n = 4)

IPAH and emphysema (n = 1)

ASD and pulmonary fibrosis (n = 1)

Pulmonary fibrosis (n = 1)

High probability (n = 8)

IPAH (n = 3)

PVOD (n = 1)

APAH and ASD (n = 2)

Scleroderma and pulmonary fibrosis (n = 1)

Apical bullae: apical mismatch on V/Q (n = 1)

Summary of False-POSITIVE V/Q Scans

IPAH = idiopathic pulmonary arterial hypertension; ASD = atrial septal defect; PVOD = pulmonary venoocclusive disease; APAH = associated pulmonary arterial hypertension

Page 16: Imaging con Scintigrafia
Page 17: Imaging con Scintigrafia

Summary of False-NEGATIVE V/Q Scans

V/Q Diagnosis2 patients from group A with low probability scan

CTPA 1. calcified thrombus in one patient and

2. narrowed but patent pulmonary arterial branches

1 patient from group A with intermediate probability scan

CT severe emphysematous

changes without signs of CTEPH

DSA CTEPH

Page 18: Imaging con Scintigrafia

*Intermediate with high-probability scans as indicative of CTEPH.

  Only high-probability scans as indicative of CTEPH.

scan

Indicator V/Q (1)* V/Q (2) CTPA

Sensitivity (%) 97.4 96.2 51.3Specificity (%) 90 94.6 99.3Accuracy (%) 92.5 95.2 82.8NPV (%) 98.5 97.9 79.7

PPV (%) 83.5 90.3 97.6

Summary of Performance Indicators for V/Q Scintigraphy and CTPA

Page 19: Imaging con Scintigrafia

PISAPED PISAPED Q J Nucl Med 2001; 45: 281

Perfusione da sola, criteri interpretativi “nuovi”, risposta SI/NO:

1) scintigrafia normale;

2) scintigrafia anormale con aspetto non embolico;

3) scintigrafia anormale con aspetto embolico

Page 20: Imaging con Scintigrafia

PISAPED PISAPED Q J Nucl Med 2001; 45: 281

• 890 pazienti

• SENSIBILITA’: 92%

• SPECIFICITA’: 87%

Interpretazione Casistica CRITERI SENS SPECSostman (PIOPED)

PISAPED PISAPED 91 90

Miniati (PISAPED)

PIOPED PISAPED 80 83

Miniati (Am J Respir Crit Care Med 1996; 154: 1387 ; Am J Respir Crit Care Med 1999; 159: 864)

Page 21: Imaging con Scintigrafia

DE

CT

V/Q scantot

PE+PE+ e altro

Altre pat

NEG

A-operati

Q dif. 50 15 0 0 65

Q unif 0 0 0 0 0

A- non operati

Q dif. 9 3 2 0 14

Q unif 0 0 0 0 0

BQ dif. 0 2 1 0 3

Q unif 2 0 2 3 7

tot 61 20 5 3 89

Stoppa D. Tesi Laurea aa.2009-10

DECT DECT vs.vs. V/Q scan V/Q scan IRCCS S.Matteo -Pavia

Page 22: Imaging con Scintigrafia

VENTILATION–PERFUSION IN CTEPH • Tunariu et al.J Nucl Med 2007; 48:680

• normal V/Q scintigraphy practically rules out the presence of CTEPH,

• whereas normal CTPA does not exclude the presence of

CTEPH.

• high probability V/Q scintigraphy makes CTEPH the most likely diagnosis, although other conditions—including pulmonary venoocclusive disease—may result in similar findings.

• grouping intermediate- with low-probability V/Q scans as indicative of non-CTEPH etiology would maintain a high sensitivity and improve specificity, NPV,and PPV.

Page 23: Imaging con Scintigrafia

V/Q Scanning for Pulmonary Hypertension

Worsley DF et al. JNM 1994;35:793

Page 24: Imaging con Scintigrafia

National Pulmonary Hypertension Centres of the UK and Ireland

Consensus statement on the management of pulmonary

hypertension in clinical practice in the UK and Ireland

Heart 2008;94;1-41

Page 25: Imaging con Scintigrafia

Diagnostic approach to chronic thromboembolic pulmonary hypertension (CTEPH).

National Pulmonary Hypertension Centres of the UK and Ireland Heart 2008;94;1-41

Page 26: Imaging con Scintigrafia

ESC/ERS GUIDELINES

FOR THE DIAGNOSIS AND

TREATMENTOF PULMONARY HYPERTENSION

Eur Respir J 2009; 34: 1219–1263

Page 27: Imaging con Scintigrafia

Contemporary Diagnostic Imaging Algorithm

Lang et al. Imaging in Pulmonary Hypertension J A C C : C A R D I O V A S C U L A R I M A G I N G . 2 0 1 0; 3:1287

Page 28: Imaging con Scintigrafia

Caso 1 - DLS

Page 29: Imaging con Scintigrafia

V

Q

DLS ♂ 68 a.

Angio: ostruzione completa rami polmonari lobari medio e inf. Dx

EAP dx & CABG

V / Q BASALE

Page 30: Imaging con Scintigrafia

ANT POST RAO

LPO LAO RPO

DLS +16 d

Page 31: Imaging con Scintigrafia

ANT POST LAO

RPO RAO LPO

ANT POST RAO

LPO LAO RPO

DLS +4m

DLS +9m

Page 32: Imaging con Scintigrafia

ANT POST RAO

LPO LAO RPO

ANT POST LAO

RPO RAO LPO

DLS +38m

DLS +26m

Page 33: Imaging con Scintigrafia

DLS +48m

RPO

ANT POST LAO

Page 34: Imaging con Scintigrafia

Caso 2 -FA

Page 35: Imaging con Scintigrafia

ANT POST RAO

LPO LAO RPO

FA ♀ 44 a , PE in gravidanza a 26 a.,dai 43 a. dispnea da sforzo, NYHA III, CT trombosi bilat aa. Polmonari, PAPs 105mmHg, ECO-Doppler DVT aa.inf.

EAP sn sup,lingula, inf dx sup, inf - lobect inf dx

V/Q BASALE

Page 36: Imaging con Scintigrafia

ANT POST RAO

LPO LAO RPO

FA +9 d

Page 37: Imaging con Scintigrafia

FA +3 m

ANT POST RAO

LPO LAO RPO

FA +3 m

Page 38: Imaging con Scintigrafia

FA +13 m

FA +26 m

ANT POST RAO

LPO LAO RPO

Page 39: Imaging con Scintigrafia

P.F.#1166 basale V/P

Page 40: Imaging con Scintigrafia

P.F.#1166 TEAP bilat: Dx S,M,I ; Sn S, Li, I

8 d - 3mo

Page 41: Imaging con Scintigrafia

P.F.#1166 TEAP bilat: DxDx S,M,I ; Sn S, Li, I

Page 42: Imaging con Scintigrafia

BL#1903 basale VP: PAPs 80mmHg. Angio-CT embolia ramo principale a polm

dx e coinvolgimento ramo lobare inf, difetto di un ramo segmentario LIS

Page 43: Imaging con Scintigrafia

BL#1903 TEAP DX (S,M,I) 8 d - 200 d

Page 44: Imaging con Scintigrafia

BL#1903 TEAP DX (S,M,I)

Page 45: Imaging con Scintigrafia

CM #1895 46 a. VP basale

Page 46: Imaging con Scintigrafia

CM #1895 46 a. DX (S,M,I) Sn (S,Li,I)

Page 47: Imaging con Scintigrafia

“Steal” after PEA 1

The incidence of new defects was increased tenfold in segments that had

(1) normal preoperative angiographic findings,

(2) normal preoperative radionuclide perfusion, and

(3) not been entered at the time of surgery.

Olman MA et al. Chest. 1990 ;98:1430-4.

Page 48: Imaging con Scintigrafia

“Steal” after PEA 2

1- hypertensive changes induced by the high flows and pressures to which the “open” vascular bed is exposed for months to years, may reduce flow to these zones postoperatively as pulmonary flow is diverted to the relatively normal microcirculation distal to endarterectomized segmental arteries.

2- the neoendothelium in the operated-on segments may create an abnormally low resistance segment in endarterectomized lung zones by its effect on vascular smooth muscle, thus shunting flow toward zones that were endarterectomized.

Olman MA et al. Chest. 1990 ;98:1430-4.

Page 49: Imaging con Scintigrafia

Role of V/Q scan in CTEPH

DIAGNOSIS High accuracy established

EARLY CHANGES AFTER PEA

sensitivePrompt visualization of Q changes

LATE CHANGES AFTER PEA

Clinical impact?

FOLLOW-UPDetection of recurrent PE

established

Page 50: Imaging con Scintigrafia

Longitudinal analysis of perfusion lung scan of patients with unoperated

CTEPH Skoro-Sajer N et al Thromb Haemost 2004; 92: 201

Perfusion scan at (A) baseline and (B) 3 yrs after

•A decrease in the crosssectional area of the pulmonary vessels leads to a loss of the functional capillary bed and vascular remodeling similar to nonthromboembolic PAH.•Within the observation period cardiac index decreased, reflecting RV decline. •Thus, the data suggest that the diagnostic V/Q scan pattern of CTEPH is lost over time, and may be misleading as the disease progresses.

Page 51: Imaging con Scintigrafia

Pulmonary Perfusion Patterns

and Pulmonary ArterialPressure

Scott JA. Radiology 2002; 224:513–518

Page 52: Imaging con Scintigrafia

Scott JA 2002

• Higher total peripheral resistances were seen with chronic PE than with acute for a given degree of vascular obstruction

• This difference was attributed to small-vessel disease in the patients with chronic PE, which was inapparent at subjective evaluation of the Q scan.

• Changes in the peripheral small vessels may thus be an important parameter in determining the PA pressure.

• Patients with primary pulmonary hypertension and CTEPH medial hypertrophy and intimal proliferation in the small distal arteries of the lung .

• This small-vessel component may alter the appearance of the lung periphery on Q scans. Although the scans of most patients with primary pulmonary hypertension lack segmental perfusion defects, the images obtained in some of these patients show a nonspecific “patchiness” that may be related to small-vessel disease

Page 53: Imaging con Scintigrafia

Fractal dimension calculation in (top row) a patient with pulmonaryhypertension (predicted pressure, 75 mm Hg; measured PA systolic [sys] pressure, 80 mm Hg) and (bottom row) a normotensive patient

(predicted pressure, 16 mm Hg, actual18 mm Hg).

Page 54: Imaging con Scintigrafia

Scatterplot of ANN-predicted PA systolic pressures versus those measured at angiography in patients with and in those without

pulmonary embolism (r 0.846, P < .001).

Page 55: Imaging con Scintigrafia

Lung Perfusion Scans Lung Perfusion Scans and Hemodynamics in and Hemodynamics in

Acute and Chronic Acute and Chronic Pulmonary EmbolismPulmonary Embolism

Réza Azarian, Myriam Wartski, Marie-Anne Collignon, Florence Parent, Philippe Hervé,Hervé Sors and

Gerald Simonneau

J Nucl Med 1997; 38:980-983

Page 56: Imaging con Scintigrafia

Relation between PVOs and TPR in Relation between PVOs and TPR in APEAPE A strong hyperbolic correlation was found

between PVOs and TPR (y = 1578/(530 - 5.88x)).

J Nucl Med 1997; 38:980

Page 57: Imaging con Scintigrafia

Relation between PVOs and TPR in APE () and CTEPH ().

For a given degree of obstruction, patients with CTEPH had higher TPR values than patients with APE.

J Nucl Med 1997; 38:980

Page 58: Imaging con Scintigrafia

Pulmonary Vascular Obstruction Pulmonary Vascular Obstruction and Hemodynamics in Acute and and Hemodynamics in Acute and

Chronic PEChronic PE

Values are expressed as means mean±s.d. (range).APE = acute pulmonary embolism; CTEPH = chronic thromboembolic pulmonary hypertension; PVOs = pulmonary vascular obstruction scoreassessed by perfusion lung scanning; PAP = mean pulmonary artery pressure; TPR = total pulmonary resistance.

J Nucl Med 1997; 38:980

Page 59: Imaging con Scintigrafia

In CTEPH patients, the higher PAP and TPR values as compared to APE patients with comparable degrees of PVOs are consistent with previous reports that

PH in CTEPH is due not only to the obstruction of proximal pulmonary arteries but also to remodeling of small distal arteries in nonoccluded areas.

J Nucl Med 1997; 38:980

Page 60: Imaging con Scintigrafia

PET & LUNG

Page 61: Imaging con Scintigrafia

(A) Regional perfusion (Q˙ r) before embolism. (B) Q˙ r after embolism: dramatic redistribution of Q˙ r with many regions of the lungs essentially unperfused. (C)Tracer activity remaining in the lungs at the end of the WO after inhalational delivery of tracer. Note that higher activity corresponds to embolized areas, representing the slower washout rate of these regions.

Page 62: Imaging con Scintigrafia

Grazie dell’attenzione

Page 63: Imaging con Scintigrafia
Page 64: Imaging con Scintigrafia
Page 65: Imaging con Scintigrafia

The 4th WHO Symposium on Pulmonary Hypertension Dana Point, California, 2008

•group 1 as pulmonary arterial hypertension (PAH),

• group 2 as pulmonary hypertension due to left heart disease,

•group 3 as pulmonary hypertension due to lung diseases and/or hypoxia,

• group 4 as chronic thromboembolic pulmonary hypertension ,

•group 5 as pulmonary hypertension of othercauses.